Paralytic Ileus, the Slowing of Food Movement Through Digestive System, is Similar to Intestinal Obstruction
(Posted by Tom Lamb at Drug Injury Watch)
In September 2023 the Ozempic (semaglutide) drug label was updated to inform doctors and
Law Offices of Thomas J. Lamb, P.A.
Website:
https://www.drug-injury.com/
Latest from Law Offices of Thomas J. Lamb, P.A. - Page 2
Ozempic / Wegovy: Stomach And Intestinal Problems Can Be Irreversible, Life-threatening
By Tom Lamb
Severe Gastric Side Effects Include Stomach Paralysis, Gastroparesis, And Intestinal Blockages
(Posted by Tom Lamb at Drug Injury Watch)
Ozempic is an increasingly popular drug for the treatment of diabetes which is used “off-label” for weight loss,…
Syfovre Adverse Reaction Cases: Updated Number of Patients With Retinal Vasculitis, Timeline of Events
By Tom Lamb
Additional Information from Apellis and the American Society of Retina Specialists About Ongoing Syfovre Safety Issues
(Posted by Tom Lamb at Drug Injury Watch)
In late July 2023, we learned more about the Syfovre adverse reaction cases…
Tepezza Drug Label Change In July 2023 Adds Warning About Severe Hearing Impairment
By Tom Lamb
Earlier Versions of Tepezza Prescribing Information Document Did Not Include Hearing Loss Side Effects
(Posted by Tom Lamb at Drug Injury Watch)
Finally, in mid-July 2023, the Tepezza drug label now includes a warning about the risks…
Syfovre Retinal Vasculitis And Severe Intraocular Inflammation Cases Reported By Ophthalmologists
By Tom Lamb
A July 2023 “Dear Doctor” Letter From Apellis Acknowledges This Developing Syfovre Safety Signal Situation
(Posted by Tom Lamb at Drug Injury Watch)
As we reported here recently, in mid-July 2023 the American Society of Retinal Specialists…
Eye Drug Syfovre Side Effects: Occlusive Retinal Vasculitis, Eye Inflammation, Vision Loss, And Blindness
By Tom Lamb
American Society of Retinal Specialists (ASRS) July 2023 Warning Letter About Adverse Events Reports Associated With Syfovre
(Posted by Tom Lamb at Drug Injury Watch)
On July 15, 2023, the American Society of Retinal Specialists (ASRS) issued…
Ozempic Side Effects: Gallbladder Diseases, Thyroid Cancer, And Suicidal Thoughts
By Tom Lamb
Diabetes and Weight-Loss Drug Ozempic Getting Scrutiny From European Drug Safety Regulator EMA
(Posted by Tom Lamb at Drug Injury Watch)
The popular weight-loss drug Ozempic (semaglutide) has been linked to gallbladder diseases which may require gallbladder…
Ozempic Gallbladder Injury Case Factors: When was the Ozempic Prescribed and For How Long?
By Tom Lamb
March 2022 Ozempic Label Change About Risks of Gallbladder Disease is Just One Part of Legal Case Analysis
(Posted by Tom Lamb at Drug Injury Watch)
An Ozempic gallbladder disease warning was the subject of a March…
Trulicity Recall Due to Dose Labeling Error Back in 2021 May Still be Drug Safety Issue Today
By Tom Lamb
Thousands of Trulicity Autoinjector Devices Labeled as 0.75 mg Might Contain 1.5 mg (i.e., a “double-dose”)
(Posted by Tom Lamb at Drug Injury Watch)
A Trulicity recall back in August – September 2021 by Eli Lilly &…
Prolia – Hypocalcemia Side Effect Safety Signal May Draw Regulatory Action by FDA
By Tom Lamb
“Risk of severe hypocalcemia” in Patients on Dialysis Receiving Osteoporosis Drug Prolia (denosumab)
(Posted by Tom Lamb at Drug Injury Watch)
The FDA is in the process of evaluating the osteoporosis drug Prolia (denosumab) to determine the…